
UTI Asset Management Q1 Results FY27: Net Profit Rises 15.76% to Rs 293 Cr as Revenue Grows 6.7%
UTI AMC Q1 FY27: PAT Rs 293 Cr (+15.76% YoY), revenue Rs 583 Cr (+6.7%). Stock fell 1.04% to Rs 909.55 on 22 July 2026.
Updated: 23 Jul 2026 • 9:59 am
Posted by:

UTI AMC Q1 results FY27, announced on Wednesday, 22 July 2026, show a consolidated net profit of Rs 293 Cr for the quarter ended 30 June 2026, up 15.76% from Rs 253 Cr in the year ago quarter.
Shares of UTI Asset Management fell 1.04% to Rs 909.55 on the results day. The company is a leading mutual fund and portfolio management company.
Click Here – Get Free Investment Predictions
UTI AMC Q1 Results FY27 Key Takeaways
Here are the most important numbers from the June 2026 quarter at a glance.
- Net Profit (PAT): Rs 293 Cr in Q1 FY27 versus Rs 253 Cr in Q1 FY26, a change of +15.76% year on year.
- Revenue: Rs 583 Cr in Q1 FY27 versus Rs 546 Cr in Q1 FY26, a change of +6.7%.
- Gross Profit: Rs 369 Cr in Q1 FY27 versus Rs 327 Cr in Q1 FY26, a change of +12.76%.
- Results announced on Wednesday, 22 July 2026 for the quarter ended 30 June 2026 on a consolidated basis.
- UTI Asset Management share price fell 1.04% to Rs 909.55 on the results day.
UTI AMC Q1 Results FY27 Financial Highlights
The table below summarises the consolidated numbers reported in the UTI AMC Q1 results FY27 against the year ago quarter.
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 583 Cr | Rs 546 Cr | +6.7% |
| Gross Profit | Rs 369 Cr | Rs 327 Cr | +12.76% |
| Net Profit (PAT) | Rs 293 Cr | Rs 253 Cr | +15.76% |
All figures are on a consolidated basis as reported for the quarter ended 30 June 2026.
UTI AMC Q1 Results FY27 Performance Analysis
Get Personalised Guidance from a SEBI-Registered Investment Advisor
Profit growth is the headline of the UTI AMC Q1 results FY27. Revenue grew 6.7% to Rs 583 Cr from Rs 546 Cr. Gross profit rose 12.76% to Rs 369 Cr from Rs 327 Cr.
Gross profit growing faster than revenue shows operating leverage at work in the UTI AMC Q1 results FY27, with margins expanding as scale builds.
UTI AMC Q1 Results FY27: Key Business Factors
1. Topline Momentum
Revenue grew 6.7% to Rs 583 Cr from Rs 546 Cr. This sets the base against which the rest of the P&L in the UTI AMC Q1 results FY27 should be read.
2. Operating Performance
Gross profit rose 12.76% to Rs 369 Cr from Rs 327 Cr. The gross profit trend is the cleanest read on operating health in the quarter.
3. Bottom Line Delivery
The net result of Rs 293 Cr captures the combined effect of operations, other income, finance costs and tax for the quarter.
Dividend Details
Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company's official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.
UTI AMC Q1 Results FY27 Outlook for the Full Year
Looking past the UTI AMC Q1 results FY27, the FY27 trajectory depends on demand conditions in the company's core markets, cost trends, and execution against the base this quarter has set.
UTI Asset Management Stock Performance After the Q1 Results
Download the Univest iOS App or Univest Android App to track UTI Asset Management live share price and upcoming quarterly results.
UTI Asset Management share price fell 1.04% to Rs 909.55 on the results day, as the market weighed the quarter's numbers against expectations.
Investors can compare the trend of the counter with the Nifty Fin Service index to judge how the stock is placed relative to the broader market after the June quarter results.
Key Risks
Investors going through the fine print of the UTI AMC Q1 results FY27 should also weigh the following risks.
1. Sustaining the Growth Rate
The growth reported in the UTI AMC Q1 results FY27 sets a higher base for coming quarters, and any moderation could disappoint a market that extrapolates.
2. Margin Durability
Whether the quarter's operating performance holds depends on input costs, pricing power and mix, all of which can shift quickly.
3. Execution and External Risks
Demand cycles, regulatory changes and sector specific shocks remain outside management control and can reset expectations.
Conclusion
UTI AMC Q1 results FY27 show consolidated net profit of Rs 293 Cr for the quarter ended 30 June 2026, up 15.76% from Rs 253 Cr in the year ago quarter. Revenue grew 6.7% to Rs 583 Cr from Rs 546 Cr. The September quarter will show whether this quarter's trend extends. Investors should verify the filings on NSE and BSE and consult a SEBI-registered advisor before acting on the numbers.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on UTI AMC Q1 Results FY27
When were the UTI AMC Q1 results FY27 announced?
Ans. The UTI AMC Q1 results FY27 were announced on Wednesday, 22 July 2026, for the quarter ended 30 June 2026, on a consolidated basis.
What is the PAT in the UTI AMC Q1 results FY27?
Ans. The consolidated PAT in the UTI AMC Q1 results FY27 stood at Rs 293 Cr, a change of +15.76% from Rs 253 Cr in Q1 FY26.
What was the revenue in the UTI AMC Q1 results FY27?
Ans. The revenue in the UTI AMC Q1 results FY27 stood at Rs 583 Cr, a change of +6.7% from Rs 546 Cr in Q1 FY26.
What was the gross profit in the UTI AMC Q1 results FY27?
Ans. Gross profit in the UTI AMC Q1 results FY27 stood at Rs 369 Cr, compared with Rs 327 Cr in Q1 FY26, a change of +12.76% year on year.
Are the UTI AMC Q1 results FY27 standalone or consolidated?
Ans. The figures discussed here are on a consolidated basis, as reported for the quarter ended 30 June 2026.
How did the share price react after the UTI AMC Q1 results FY27?
Ans. UTI Asset Management share price fell 1.04% to Rs 909.55 on the results day.
Is the stock a good buy after the UTI AMC Q1 results FY27?
Ans. The UTI AMC Q1 results FY27 are one input among many. Valuation, sector conditions and risk appetite matter as much as a single quarter. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.
Where can I verify the UTI AMC Q1 results FY27?
Ans. The official filings for the UTI AMC Q1 results FY27 are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.
Recent Articles

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan IDCW Payout vs Bank of India Mid Cap Tax Fund Series 1 Direct IDCW: NAV, Returns and Maturity Status Compared
28 July 2026

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs ICICI Prudential R.I.G.H.T. IDCW: NAV, Returns and Maturity Status Compared
28 July 2026

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs Bank of India Mid Cap Tax Fund Series 2 Direct IDCW: NAV, Returns and Maturity Status Compared
28 July 2026

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs Bank of India Mid Cap Tax Fund Series 2 Regular Growth: NAV, Returns and Maturity Status Compared
28 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan IDCW Payout vs Bank of India Mid Cap Tax Fund Series 1 Direct IDCW: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs ICICI Prudential R.I.G.H.T. IDCW: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs Bank of India Mid Cap Tax Fund Series 2 Direct IDCW: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs Bank of India Mid Cap Tax Fund Series 2 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan IDCW Payout vs ICICI Prudential Wealth Enhancement Fund: NAV, Returns and Maturity Status Compared
Popular this week
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan IDCW Payout vs Bank of India Mid Cap Tax Fund Series 1 Direct IDCW: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs ICICI Prudential R.I.G.H.T. IDCW: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs Bank of India Mid Cap Tax Fund Series 2 Direct IDCW: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs Bank of India Mid Cap Tax Fund Series 2 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan IDCW Payout vs ICICI Prudential Wealth Enhancement Fund: NAV, Returns and Maturity Status Compared

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





